BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 16924083)

  • 1. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
    Teh SH; Deveney C; Sheppard BC
    Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central pancreatectomy: single-center experience of 50 cases.
    Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
    Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.
    Sarmiento JM; Farnell MB; Que FG; Nagorney DM
    World J Surg; 2002 Oct; 26(10):1267-71. PubMed ID: 12205558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
    Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery in malignant pancreatic neuroendocrine tumors.
    Nguyen SQ; Angel LP; Divino CM; Schluender S; Warner RR
    J Surg Oncol; 2007 Oct; 96(5):397-403. PubMed ID: 17469119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors.
    Le Borgne J; Partensky C; Glemain P; Dupas B; de Kerviller B
    Hepatogastroenterology; 2000; 47(32):540-4. PubMed ID: 10791233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
    Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
    JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.
    Falconi M; Zerbi A; Crippa S; Balzano G; Boninsegna L; Capitanio V; Bassi C; Di Carlo V; Pederzoli P
    Ann Surg Oncol; 2010 Jun; 17(6):1621-7. PubMed ID: 20162460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
    J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival.
    Faure JP; Tuech JJ; Richer JP; Pessaux P; Arnaud JP; Carretier M
    J Urol; 2001 Jan; 165(1):20-2. PubMed ID: 11125354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreaticoduodenectomy for selected pancreatic endocrine tumors.
    Udelsman R; Yeo CJ; Hruban RH; Pitt HA; Niederhuber JE; Coleman J; Cameron JL
    Surg Gynecol Obstet; 1993 Sep; 177(3):269-78. PubMed ID: 8102815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic resection for metastatic tumors to the pancreas.
    Sperti C; Pasquali C; Liessi G; Pinciroli L; Decet G; Pedrazzoli S
    J Surg Oncol; 2003 Jul; 83(3):161-6; discussion 166. PubMed ID: 12827684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.